You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies

Article info

Article menu

Download PDFPDF

XML
Research Article
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies

Authors

  • Victoria M. Kim The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of SurgeryThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Alex B. Blair The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of SurgeryThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Peter Lauer Aduro Biotech, Inc. Berkeley California USA PubMed articlesGoogle scholar articles
  • Kelly Foley The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Xu Che The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Kevin Soares The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of SurgeryThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Tao Xia The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Stephen T. Muth The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Jennifer Kleponis The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Todd D. Armstrong The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Christopher L. Wolfgang The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of SurgeryThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Elizabeth M. Jaffee The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Dirk Brockstedt Aduro Biotech, Inc. Berkeley California USA PubMed articlesGoogle scholar articles
  • Lei Zheng The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of OncologyThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA Department of SurgeryThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA The Pancreatic Cancer Precision Medicine Program of ExcellenceThe Johns Hopkins University School of Medicine 21287 Baltimore MD USA PubMed articlesGoogle scholar articles
  1. ↵n 410-5026241 lzheng6{at}jhmi.edu
View Full Text

Citation

Kim VM, Blair AB, Lauer P, et al
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies
Journal for ImmunoTherapy of Cancer 2019;7:132. doi: 10.1186/s40425-019-0601-5

Publication history

  • Received January 10, 2019
  • Accepted April 23, 2019
  • First published May 22, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.